Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by DeRose Kathleen, Director. Insider active across 1 company, notably Enfusion, Inc.. Cumulatively, 6 filings have been published. Activity tracked since 31 October 2021. The latest transaction was filed on 13 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Kathleen DeRose is a Board Member at Enfusion, Inc. In this role, she participates in overseeing the company's activities and making strategic decisions. Her experience in the fintech sector allows her to make significant contributions to the board.